Catalyst Wire Dossier Catalyst Wire Dossier

CMV-specific T cells (adoptive immunotherapy)

CMV-specific T cells · Fred Hutchinson Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMV-specific T cells (adoptive immunotherapy), covering 2010-08-24 to 2010-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

See pricing